New Prospects of Cytoprotection in the Treatment and Prevention of Gastric and Intestinal Diseases (Resolution of an Expert Council and Literature Review)

Aim. To generalize up-to-date information on the possibilities of cytoprotection in the treatment and prevention of gastric and intestinal diseases, as well as to present the materials of an Expert Council meeting held on February 8, 2020 in Moscow under the support of the Alium company.General prov...

Full description

Saved in:
Bibliographic Details
Main Authors: A. I. Martynov, A. A. Sheptulin, I. V. Mayev, A. N. Kazyulin, A. Ye. Karateev, A. V. Melekhov, L. K. Pal’gova, K. L. Raikhel’son
Format: Article
Language:Russian
Published: Gastro LLC 2020-05-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
Online Access:https://www.gastro-j.ru/jour/article/view/477
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860135690240000
author A. I. Martynov
A. A. Sheptulin
I. V. Mayev
A. N. Kazyulin
A. Ye. Karateev
A. V. Melekhov
L. K. Pal’gova
K. L. Raikhel’son
author_facet A. I. Martynov
A. A. Sheptulin
I. V. Mayev
A. N. Kazyulin
A. Ye. Karateev
A. V. Melekhov
L. K. Pal’gova
K. L. Raikhel’son
author_sort A. I. Martynov
collection DOAJ
description Aim. To generalize up-to-date information on the possibilities of cytoprotection in the treatment and prevention of gastric and intestinal diseases, as well as to present the materials of an Expert Council meeting held on February 8, 2020 in Moscow under the support of the Alium company.General provisions. The conducted Expert Council meeting was aimed at discussing the importance of improving the cytoprotective properties of the gastric and intestinal mucous membrane in the treatment of its lesions. It was shown that Rebamipide exhibits positive effects on various parts of the protective barrier of the gastrointestinal tract (GIT), primarily due to its stimulating action on the production of prostaglandins playing a key role in maintaining the cytoprotective properties of the gastrointestinal mucosa. The possibilities of applying Rebamipide for the treatment and prevention of erosive and ulcerative gastrointestinal lesions caused by non-steroidal anti-inflammatory (NSAIDs) and antithrombotic drugs were demonstrated. In the treatment of gastroesophageal reflux disease, Rebamipide is recommended for patients refractory to therapy with proton pump inhibitors (PPIs) and for those with non-acid reflux. The efficacy of Rebamipide in the treatment of Helicobacter pylori (H. pylori) infection, as well as functional dyspepsia and chronic gastritis, was confirmed.Conclusions. Rebamipid is a highly effective drug positively affecting various cytoprotection links, thus being suitable for the treatment and prevention of erosive and ulcerative lesions of the gastrointestinal tract, as well as gastroenterological diseases of various etiologies.Conflict of interest: The Expert Council meeting was supported by the Alium company.
format Article
id doaj-art-75af2884c15e4d9fa9e6f4be2e80cefa
institution Kabale University
issn 1382-4376
2658-6673
language Russian
publishDate 2020-05-01
publisher Gastro LLC
record_format Article
series Российский журнал гастроэнтерологии, гепатологии, колопроктологии
spelling doaj-art-75af2884c15e4d9fa9e6f4be2e80cefa2025-02-10T16:14:36ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732020-05-0130271410.22416/1382-4376-2020-30-2-7-14364New Prospects of Cytoprotection in the Treatment and Prevention of Gastric and Intestinal Diseases (Resolution of an Expert Council and Literature Review)A. I. Martynov0A. A. Sheptulin1I. V. Mayev2A. N. Kazyulin3A. Ye. Karateev4A. V. Melekhov5L. K. Pal’gova6K. L. Raikhel’son7A.I. Yevdokimov Moscow State University of Medicine and DentistryI.M. Sechenov First Moscow State Medical UniversityA.I. Yevdokimov Moscow State University of Medicine and DentistryA.I. Yevdokimov Moscow State University of Medicine and DentistryV.A. Nasonova Scientific Research Institute of RheumatologyPirogov Russian National Research Medical UniversitySt. Petersburg State UniversitySt. Petersburg State UniversityAim. To generalize up-to-date information on the possibilities of cytoprotection in the treatment and prevention of gastric and intestinal diseases, as well as to present the materials of an Expert Council meeting held on February 8, 2020 in Moscow under the support of the Alium company.General provisions. The conducted Expert Council meeting was aimed at discussing the importance of improving the cytoprotective properties of the gastric and intestinal mucous membrane in the treatment of its lesions. It was shown that Rebamipide exhibits positive effects on various parts of the protective barrier of the gastrointestinal tract (GIT), primarily due to its stimulating action on the production of prostaglandins playing a key role in maintaining the cytoprotective properties of the gastrointestinal mucosa. The possibilities of applying Rebamipide for the treatment and prevention of erosive and ulcerative gastrointestinal lesions caused by non-steroidal anti-inflammatory (NSAIDs) and antithrombotic drugs were demonstrated. In the treatment of gastroesophageal reflux disease, Rebamipide is recommended for patients refractory to therapy with proton pump inhibitors (PPIs) and for those with non-acid reflux. The efficacy of Rebamipide in the treatment of Helicobacter pylori (H. pylori) infection, as well as functional dyspepsia and chronic gastritis, was confirmed.Conclusions. Rebamipid is a highly effective drug positively affecting various cytoprotection links, thus being suitable for the treatment and prevention of erosive and ulcerative lesions of the gastrointestinal tract, as well as gastroenterological diseases of various etiologies.Conflict of interest: The Expert Council meeting was supported by the Alium company.https://www.gastro-j.ru/jour/article/view/477gastric and intestial mucosacytoprotectionrebamipid
spellingShingle A. I. Martynov
A. A. Sheptulin
I. V. Mayev
A. N. Kazyulin
A. Ye. Karateev
A. V. Melekhov
L. K. Pal’gova
K. L. Raikhel’son
New Prospects of Cytoprotection in the Treatment and Prevention of Gastric and Intestinal Diseases (Resolution of an Expert Council and Literature Review)
Российский журнал гастроэнтерологии, гепатологии, колопроктологии
gastric and intestial mucosa
cytoprotection
rebamipid
title New Prospects of Cytoprotection in the Treatment and Prevention of Gastric and Intestinal Diseases (Resolution of an Expert Council and Literature Review)
title_full New Prospects of Cytoprotection in the Treatment and Prevention of Gastric and Intestinal Diseases (Resolution of an Expert Council and Literature Review)
title_fullStr New Prospects of Cytoprotection in the Treatment and Prevention of Gastric and Intestinal Diseases (Resolution of an Expert Council and Literature Review)
title_full_unstemmed New Prospects of Cytoprotection in the Treatment and Prevention of Gastric and Intestinal Diseases (Resolution of an Expert Council and Literature Review)
title_short New Prospects of Cytoprotection in the Treatment and Prevention of Gastric and Intestinal Diseases (Resolution of an Expert Council and Literature Review)
title_sort new prospects of cytoprotection in the treatment and prevention of gastric and intestinal diseases resolution of an expert council and literature review
topic gastric and intestial mucosa
cytoprotection
rebamipid
url https://www.gastro-j.ru/jour/article/view/477
work_keys_str_mv AT aimartynov newprospectsofcytoprotectioninthetreatmentandpreventionofgastricandintestinaldiseasesresolutionofanexpertcouncilandliteraturereview
AT aasheptulin newprospectsofcytoprotectioninthetreatmentandpreventionofgastricandintestinaldiseasesresolutionofanexpertcouncilandliteraturereview
AT ivmayev newprospectsofcytoprotectioninthetreatmentandpreventionofgastricandintestinaldiseasesresolutionofanexpertcouncilandliteraturereview
AT ankazyulin newprospectsofcytoprotectioninthetreatmentandpreventionofgastricandintestinaldiseasesresolutionofanexpertcouncilandliteraturereview
AT ayekarateev newprospectsofcytoprotectioninthetreatmentandpreventionofgastricandintestinaldiseasesresolutionofanexpertcouncilandliteraturereview
AT avmelekhov newprospectsofcytoprotectioninthetreatmentandpreventionofgastricandintestinaldiseasesresolutionofanexpertcouncilandliteraturereview
AT lkpalgova newprospectsofcytoprotectioninthetreatmentandpreventionofgastricandintestinaldiseasesresolutionofanexpertcouncilandliteraturereview
AT klraikhelson newprospectsofcytoprotectioninthetreatmentandpreventionofgastricandintestinaldiseasesresolutionofanexpertcouncilandliteraturereview